Event-free and absolute survival from the date of diagnosis concerning objective 1 and from the date of randomisation concerning objective 2 5 years [clinicaltrials_resource:536317f1423bfe5c0fffe0237f5eeb4d]

Daunoxome, standard risk

Event-free and absolute survival from the date of diagnosis concerning objective 1 and from the date of randomisation concerning objective 2 5 years [clinicaltrials_resource:536317f1423bfe5c0fffe0237f5eeb4d]

Daunoxome, standard risk